HomeTCRX • NASDAQ
add
Tscan Therapeutics Inc
Previous close
$5.26
Day range
$5.16 - $5.36
Year range
$2.86 - $9.69
Market cap
281.82M USD
Avg Volume
204.19K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 536.00K | -82.97% |
Operating expense | 7.77M | 19.02% |
Net income | -31.66M | -31.67% |
Net profit margin | -5.91K | -673.34% |
Earnings per share | -0.28 | 45.10% |
EBITDA | -33.00M | -41.54% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 297.68M | 42.54% |
Total assets | 374.87M | 18.28% |
Total liabilities | 119.65M | -5.28% |
Total equity | 255.22M | — |
Shares outstanding | 52.97M | — |
Price to book | 1.09 | — |
Return on assets | -27.70% | — |
Return on capital | -30.40% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -31.66M | -31.67% |
Cash from operations | -26.22M | -19.09% |
Cash from investing | -33.72M | -7,927.62% |
Cash from financing | 161.59M | 19.10% |
Net change in cash | 101.65M | -10.23% |
Free cash flow | -15.97M | 24.91% |
About
Founded
2018
Headquarters
Website
Employees
175